| #43 |
Philip Barth |
Polyphor Ag |
1 |
| #43 |
Alexander Boris Schwahn |
Dionex |
1 |
| #43 |
Klaus-Peter MOLL |
Novartis Ag |
1 |
| #43 |
Hans de Waard |
Novartis Ag |
1 |
| #43 |
Adrianus Antonius Johannes Van Geel |
Dsm Ip Assets B.V. |
1 |
| #43 |
Patrizia Murer |
— |
1 |
| #43 |
Daniel Hunziker |
Basilea Pharmaceutica Ag |
1 |
| #43 |
Rudolf Walchli |
Novartis Ag |
1 |
| #43 |
Anne-Hortense Schmitt-Hoffmann |
Glaxo Group Limited |
1 |
| #43 |
Simon Brenner |
Invacare International Gmbh |
1 |
| #43 |
Alessandra Franchino |
— |
1 |
| #43 |
Walter Ferlin |
Novimmune Sa |
1 |
| #43 |
Ellen OBERMANN |
University Of Basel |
1 |
| #43 |
Maximilian Marhöfer |
Sensile Medical Ag |
1 |
| #43 |
Ulrich HOELLER |
Dsm Ip Assets B.V. |
1 |
| #43 |
Lorenz Waldmeier |
Nbe-Therapeutics Ag |
1 |
| #43 |
Martin Szelagiewicz |
Basf Se |
1 |
| #43 |
Stephan Roever |
Hoffmann-La Roche |
1 |
| #43 |
Zorica DRAGIC |
Novartis Ag |
1 |
| #43 |
Felipe José Oliveira Varum |
Tillotts Pharma Ag |
1 |
| #43 |
Kai Urban |
Dsm Ip Assets B.V. |
1 |
| #43 |
Masato Hoshino |
Nissan Motor Co. |
1 |
| #43 |
Marc Hollmach |
Endress+Hauser Flowtec Ag |
1 |
| #43 |
Stephan Gysin |
University of California |
1 |
| #43 |
Jan Pflug |
Endress+Hauser Process Solutions Ag |
1 |
| #43 |
Joerg Duschmalé |
Hoffmann-La Roche |
1 |
| #43 |
Jean-Pierre Pauchard |
Straumann Holding Ag |
1 |
| #43 |
Ivan Pogorelic |
Idorsia Pharmaceuticals |
1 |
| #43 |
Norbert Markuly |
— |
1 |
| #43 |
Irene Hunt |
Novartis Ag |
1 |
| #43 |
Stefano Brianza |
Ao Technology Ag |
1 |
| #43 |
Marie-Christine Wolf |
Array Biopharma |
1 |
| #43 |
Anna Svenja Schubart |
Novartis Ag |
1 |
| #43 |
Jerome Hert |
Hoffmann-La Roche |
1 |
| #43 |
Hans Tobler |
Syngenta Crop Protection Ag |
1 |
| #43 |
Helene Jeanne SAHRI |
Hoffmann-La Roche |
1 |
| #43 |
Daniela Angst |
Novartis Ag |
1 |
| #43 |
Claudia Mueller |
Novartis Ag |
1 |
| #43 |
JEANNETTE FAREH-MICHIEL |
— |
1 |
| #43 |
Daniella Cheang |
Hoffmann-La Roche |
1 |
| #43 |
Elisabeth SCHAIBLE |
Genentech |
1 |
| #43 |
Raphael Beumer |
Dsm Ip Assets B.V. |
1 |
| #43 |
Carina CANTRILL |
Hoffmann-La Roche |
1 |
| #43 |
Roman Mathaes |
Lonza |
1 |
| #43 |
Atanas Koulov |
Lonza |
1 |
| #43 |
Jan Schlomach |
Novartis Ag |
1 |
| #43 |
Abel Ferrandez |
Dsm Ip Assets B.V. |
1 |
| #43 |
Matilde ARÉVALO-RUIZ |
— |
1 |
| #43 |
Roberto Iacone |
Hoffmann-La Roche |
1 |
| #43 |
Tarik Ali Khan |
Genentech |
1 |